{
  "trial_id": "NCT03033758",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Male and Female",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Patients about to start treatment with the inhaled combination of budesonide and formoterol fumarate dihydrate at doses 100 / 6mcg, 200 / 6mcg, 400/12 mcg, through Elpenhlaler device",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Regular treatment of asthma, wherein the administration of the combination (inhaled corticosteroid and long-action beta2-agonist) is appropriate",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled beta2-agonists short-acting",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Patients who signed Informed Consent Patients eligible to follow the study procedures",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients who will be treated out of SpC",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Patients without Informed Consent",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "A 39-year-old man with a history of asthma, experiencing symptoms despite treatment. Spirometry revealed FEV1 of 63% predicted.",
  "_meta": {
    "topic_id": "23",
    "trial_id": "NCT03033758",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}